Literature DB >> 8911277

The association of hyperestrogenemia with coronary thrombosis in men.

G B Phillips1, B H Pinkernell, T Y Jing.   

Abstract

Both hyperestrogenemia and hypotestosteronemia have been reported in association with myocardial infarction (MI) in men. It was previously observed that the serum testosterone concentration correlated negatively with the degree of coronary artery disease (CAD) in men who had never had a known MI. The present study investigated the relationship of sex hormone levels to the thrombotic component of MI by comparing these levels in 18 men who had had an MI (ie, thrombosis) and 50 men with no history of MI (ie, no thrombosis) whose degree of CAD was in the same range. The mean degree of CAD, age, and body mass index in these two groups was not significantly different. The mean serum estradiol level in the men who had had an MI (38.5 +/- 8.8 pg/mL) was higher (P = .002) than the level in the men who had not had an MI (31.9 +/- 7.1 pg/mL). The mean levels of testosterone, free testosterone, sex hormone-binding globulin, insulin, dehydroepiandrosterone sulfate, cholesterol, HDI, cholesterol, and systolic and diastolic blood pressure did not differ significantly. Estradiol was the only variable measured that showed a significant relationship to MI (P < .003 by multivariate logistic regression). These findings suggest that hyperestrogenemia may be related to the thrombosis of MI.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8911277     DOI: 10.1161/01.atv.16.11.1383

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  9 in total

1.  Estradiol and inflammatory markers in older men.

Authors:  Marcello Maggio; Gian Paolo Ceda; Fulvio Lauretani; Stefania Bandinelli; E Jeffrey Metter; Andrea Artoni; Elisa Gatti; Carmelinda Ruggiero; Jack M Guralnik; Giorgio Valenti; Shari M Ling; Shehzad Basaria; Luigi Ferrucci
Journal:  J Clin Endocrinol Metab       Date:  2008-12-02       Impact factor: 5.958

Review 2.  The role of testosterone therapy in cardiovascular mortality: culprit or innocent bystander?

Authors:  Monique S Tanna; Arthur Schwartzbard; Jeffery S Berger; Joseph Alukal; Howard Weintraub
Journal:  Curr Atheroscler Rep       Date:  2015-03       Impact factor: 5.113

3.  Estradiol and metabolic syndrome in older italian men: The InCHIANTI Study.

Authors:  Marcello Maggio; Fulvio Lauretani; Gian Paolo Ceda; Stefania Bandinelli; Shehzad Basaria; Giuseppe Paolisso; Claudio Giumelli; Michele Luci; Samer S Najjar; E Jeffrey Metter; Giorgio Valenti; Jack Guralnik; Luigi Ferrucci
Journal:  J Androl       Date:  2008-12-04

4.  Circulating Sex Steroids and Vascular Calcification in Community-Dwelling Men: The Framingham Heart Study.

Authors:  Thomas G Travison; Christopher J O'Donnell; Shalender Bhasin; Joseph M Massaro; Udo Hoffmann; Ramachandran S Vasan; Ralph B D'Agostino; Shehzad Basaria
Journal:  J Clin Endocrinol Metab       Date:  2016-03-01       Impact factor: 5.958

5.  Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation.

Authors:  Shehzad Basaria; Maithili N Davda; Thomas G Travison; Jagadish Ulloor; Ravinder Singh; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-05-04       Impact factor: 6.053

6.  Myocardial Infarction and Stroke Risk in Young Healthy Men Treated with Injectable Testosterone.

Authors:  Robert S Tan; Kelly R Cook; William G Reilly
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

7.  Endogenous Estradiol and Testosterone may Predispose toward Atherogenic Lipid Profile, but Higher Blood Level of Testosterone is Associated with Lower Number of Stenoses in the Coronary Arteries of Men with Coronary Disease.

Authors:  Jerzy Krzysztof Wranicz; Iwona Cygankiewicz; Piotr Kula; Renata Walczak-Jedrzejowska; Jolanta Slowikowska-Hilczer; Krzysztof Kula
Journal:  Int J Biomed Sci       Date:  2006-06

Review 8.  Worse progression of COVID-19 in men: Is testosterone a key factor?

Authors:  Vito A Giagulli; Edoardo Guastamacchia; Thea Magrone; Emilio Jirillo; Giuseppe Lisco; Giovanni De Pergola; Vincenzo Triggiani
Journal:  Andrology       Date:  2020-06-28       Impact factor: 4.456

Review 9.  Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failure.

Authors:  Baris Gencer; Marco Bonomi; Maria Pia Adorni; Cesare R Sirtori; François Mach; Massimiliano Ruscica
Journal:  Rev Endocr Metab Disord       Date:  2021-02-22       Impact factor: 6.514

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.